These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7258754)
41. Endotracheal bretylium tosylate in a canine model. Murphy KM; Caplen SM; Nowak RM; Lin WN; Kelly AR; Slocombe R; Tomlanovich MC Ann Emerg Med; 1984 Feb; 13(2):87-91. PubMed ID: 6419651 [TBL] [Abstract][Full Text] [Related]
42. The influence of bretylium tosylate on the intraocular pressure of the rabbit. Krieglstein GK Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Nov; 197(2):153-8. PubMed ID: 1082263 [TBL] [Abstract][Full Text] [Related]
43. Bretylium tosylate in the management of refractory ventricular fibrillation. Dhurandhar RW; Teasdale SJ; Mahon WA Can Med Assoc J; 1971 Jul; 105(2):161-5 passim. PubMed ID: 5556280 [TBL] [Abstract][Full Text] [Related]
44. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation. Euler DE; Zeman TW; Wallock ME; Scanlon PJ Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284 [TBL] [Abstract][Full Text] [Related]
45. Effects of bretylium tosylate during experimental cardiac arrest. DeBehnke DJ Am J Emerg Med; 1991 Jul; 9(4):398. PubMed ID: 2054013 [No Abstract] [Full Text] [Related]
46. [Use of bretylium tosylate in ventricular fibrillation]. Arcidiacono R Clin Ter; 1978 Feb; 84(3):253-66. PubMed ID: 346298 [No Abstract] [Full Text] [Related]
50. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium. Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638 [TBL] [Abstract][Full Text] [Related]
51. Prevention of ventricular fibrillation during hypothermia with bretylium tosylate. Buckley JJ; Bosch OK; Bacaner MB Anesth Analg; 1971; 50(4):587-93. PubMed ID: 5105113 [No Abstract] [Full Text] [Related]
52. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction]. Kochmański M; Rdzanek H; Zochowski RJ Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893 [TBL] [Abstract][Full Text] [Related]
53. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111 [TBL] [Abstract][Full Text] [Related]
55. Bretylium: a prototype for future development of antidysrhythmic agents. Patterson E; Lucchesi BR Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235 [No Abstract] [Full Text] [Related]
56. Comparison of bretylium and lidocaine in the prevention of ventricular fibrillation after aortic cross-clamp release in coronary artery bypass surgery. Kirlangitis J; Middaugh R; Knight R; Goglin W; Helsel R; Grishkin B; Briggs R J Cardiothorac Anesth; 1990 Oct; 4(5):582-7. PubMed ID: 2132137 [TBL] [Abstract][Full Text] [Related]
57. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of bretylium tosylate for the treatment of premature ventricular contractions. Romhilt DW; Bloomfield SS; Lipicky RJ; Welch RM; Fowler NO Circulation; 1972 Apr; 45(4):800-7. PubMed ID: 4111476 [No Abstract] [Full Text] [Related]
59. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug]. Dłuzniewski M Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282 [No Abstract] [Full Text] [Related]
60. Effect of bretylium tosylate on the prevention and treatment of postoperative arrhythmias. Castaneda AR; Bacaner MB Am J Cardiol; 1970 Apr; 25(4):461-6. PubMed ID: 5438242 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]